Font Size: a A A
Keyword [TO901317]
Result: 1 - 11 | Page: 1 of 1
1. Activation Of LXR By T0901317 Causes An Increases In DBP And CYP46 Expression And A Decrease In Aβ Level In Mouse Brains
2. The Liver X Receptor Agonist TO901317 Protects Mice Against Cisplatin-induced Kidney Injury
3. Effect Of Liver X Receptor Activation On Transformation Of Radial Glial Cells In The Hippocampus Of Wild Type And Alzheimer’s Disease Mouse And Its Mechanism
4. To901317Inhibits The Proliferation Of MCF-7Human Breast Cancer Cells By The Pathway Of LXRα/NF-κB P65/CyclinD1
5. TO901317 Inhibits The Invasion And Migration Of MCF-7 Human Breast Cancer Cells By LXRα/NF-κB P65/MMP9
6. TO901317 Induces Apoptosis In MCF-7 And MDA-MB-231 Human Breast Cancer Cells
7. Amelioration Of Amyloid Î’ Induced Retinal Inflammatory Responses By A LXR Agonist TO901317 Is Associated With Inactivation Of The NF-ΚB Signaling And NLRP3 Inflammasome
8. The Effect Of LXR Agonist TO901317 On Myocardial Infla-mmation And Autophagy In Neonatal Mice Induced By LPS
9. TO901317 Inhibits The Progress Of Liver Cancer By Liver X Receptor α Down-regulating The Glucose Metabolism
10. TO901317 Promotes GF To Induce Differentiation Of Human Bone Marrow Mesenchymal Cells Into Dopamine Neurons
11. Mechanism Of TO901317 Regulating IL-1β/VEGF Pathway To Inhibit Neovascularization In Diabetic Retinopathy
  <<First  <Prev  Next>  Last>>  Jump to